open access

Vol 7, No 3 (2011)
Review paper
Published online: 2011-08-23
Get Citation

Treosulfan in treatment of advanced ovarian cancer and metastatic cutaneous and eyeball malignant melanoma

Krzysztof Krzemieniecki, Aneta L. Zygulska
Onkol. Prak. Klin 2011;7(3):127-131.

open access

Vol 7, No 3 (2011)
REVIEW ARTICLES
Published online: 2011-08-23

Abstract

Treosulfan is an alkylating agent with mild toxicity and proven clinical activity in the treatment of advanced ovarian cancer, cutaneous and uveal melanoma. According to authors treosulfan is worth to be used more wildly in everyday practice and requires further studies in some clinical indictations.
Onkol. Prak. Klin. 2011; 7, 3: 127–131

Abstract

Treosulfan is an alkylating agent with mild toxicity and proven clinical activity in the treatment of advanced ovarian cancer, cutaneous and uveal melanoma. According to authors treosulfan is worth to be used more wildly in everyday practice and requires further studies in some clinical indictations.
Onkol. Prak. Klin. 2011; 7, 3: 127–131
Get Citation

Keywords

treosulfan; ovarian cancer; cutaneous melanoma; uveal melanoma

About this article
Title

Treosulfan in treatment of advanced ovarian cancer and metastatic cutaneous and eyeball malignant melanoma

Journal

Oncology in Clinical Practice

Issue

Vol 7, No 3 (2011)

Article type

Review paper

Pages

127-131

Published online

2011-08-23

Bibliographic record

Onkol. Prak. Klin 2011;7(3):127-131.

Keywords

treosulfan
ovarian cancer
cutaneous melanoma
uveal melanoma

Authors

Krzysztof Krzemieniecki
Aneta L. Zygulska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl